Floatz logo

Peginterferon

Unipolar Depression

New York State Psychiatric InstituteN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Unipolar Depression cohort.

Asset / SponsorPhaseRating
Cystadane
Cambridge Health Alliance
Phase 4BB
L-METHIONINE
Cambridge Health Alliance
Phase 4BB
Folate
Cambridge Health Alliance
Phase 4BB
Erythropoietin Human Recombinant
Lars Vedel Kessing
Phase 2B
Enoxolone
Philipps University Marburg
Phase 1/2CCC
Telaprevir
New York State Psychiatric Institute
N/AD
Boceprevir
New York State Psychiatric Institute
N/AD

Same molecule, other indications

Peginterferon is also rated in:

hepatitis C virus infectionDormant
BBB
Indicative ·
75 / 100
View asset →
Nonalcoholic Fatty Liver DiseaseDormant
BB
Indicative ·
65 / 100
View asset →
Chronic Hepatitis bDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →